NanoVation Therapeutics
Vancouver, CA · 1 known investors
NanoVation Therapeutics develops lipid nanoparticle (LNP) formulations for delivering nucleic acids in genetic medicine development. The company provides customizable LNP platforms, RNA modifications, and co-development services to partners developing therapies based on mRNA, siRNA, DNA and other nucleic acid payloads.